4//SEC Filing
GALLOWAY CHRISTOPHER D 4
Accession 0001437749-22-001915
CIK 0001053691other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:06 AM ET
Size
5.4 KB
Accession
0001437749-22-001915
Insider Transaction Report
Form 4
GALLOWAY CHRISTOPHER D
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-27+305,743→ 305,743 totalExercise: $0.24Exp: 2032-01-27→ Common Stock (305,743 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeother
Related Parties
1- filerCIK 0001829319
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 6:06 AM ET
- Size
- 5.4 KB